Theophylline
Theophylline is a prescription medication available as extended-release tablets (400mg and 600mg) for oral use, manufactured by Glenmark Pharmaceuticals Inc., USA. It belongs to the methylxanthine class and is used to help relax the muscles in the airways, making it easier to breathe for conditions like asthma or COPD. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Theophylline is a prescription medication available as extended-release tablets (400mg and 600mg) for oral use, manufactured by Glenmark Pharmaceuticals Inc., USA. It belongs to the methylxanthine class and is used to help relax the muscles in the airways, making it easier to breathe for conditions like asthma or COPD. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Theophylline",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Theophylline — ANDA 090430 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090430"
}
]
|
| identifier | ANDA090430 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Theophylline |
